ASTRAZENECA PLC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net Income $3.3b $6.0b $7.0b $10.2b
Net Income From Continuing Operations $2.5b $6.9b $8.7b $12.4b
Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss $2.4b $3.0b $3.8b $3.8b $3.1b $6.5b $5.5b $5.4b $6.7b $5.7b
Amortization Cash Flow $4.2b $3.9b $3.9b $4.2b
Depreciation $1.1b $1.0b $1.1b $1.3b
Depreciation, amortisation and impairment $2.4b $3.0b $3.8b $3.8b $3.1b $6.5b $5.5b $5.4b $6.7b $5.7b
Adjustments For Deferred Tax Of Prior Periods ($130.0m) $94.0m ($162.0m) ($113.0m) ($21.0m) ($158.0m) $135.0m ($34.0m) $23.0m ($47.0m)
Adjustments For Share-Based Payments $241.0m $220.0m $219.0m $259.0m $277.0m $615.0m $619.0m $579.0m $660.0m $719.0m
Additional Financial Items
Acquisition of subsidiaries, net of cash acquired ($9.3b) ($48.0m) ($189.0m) ($2.8b) ($66.0m)
Adjustments For Current Tax Of Prior Period ($14.0m) ($287.0m) $38.0m $66.0m ($10.0m) ($5.0m) ($187.0m) $28.0m ($107.0m) ($60.0m)
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates $776.0m $13.0m
Adjustments For Unrealised Foreign Exchange Losses Gains ($264.0m) ($13.0m) ($146.0m) ($141.0m) ($37.0m) ($182.0m) ($590.0m) $128.0m ($193.0m) $201.0m
Beginning Cash Position $6.0b $6.0b $5.6b $5.4b
Cash generated from operations $5.2b $4.7b $3.8b $4.9b $7.1b $8.4b $12.3b $13.8b $15.9b $18.7b
Change In Inventory $3.9b ($669.0m) ($131.0m) ($755.0m)
Change In Payable $1.2b $2.4b $862.0m $1.3b
Change In Receivables ($1.3b) ($1.4b) ($1.6b) ($1.7b)
Change In Working Capital $3.8b $300.0m ($893.0m) ($1.1b)
Changes In Cash $25.0m ($286.0m) ($115.0m) $223.0m
Disposal of intangible assets $1.4b $1.4b $2.3b $2.1b $951.0m $587.0m $447.0m $291.0m $123.0m $136.0m
Disposal of investments in associates and joint ventures $776.0m $13.0m
Disposal of non-current asset investments $3.0m $70.0m $24.0m $18.0m $1.4b $9.0m $42.0m $32.0m $78.0m
End Cash Position $6.0b $5.6b $5.4b $5.7b
Fair value movements on contingent consideration arising from business combinations ($1.2b) $109.0m ($495.0m) ($614.0m) ($272.0m) $14.0m $82.0m $549.0m $311.0m ($97.0m)
Finance income and expense $1.3b $1.4b $1.3b $1.3b $1.2b $1.3b $1.3b $1.3b $1.3b $1.3b
Financing Cash Flow ($6.8b) ($6.6b) ($4.0b) ($7.5b)
Free Cash Flow $7.2b $6.6b $7.3b $8.7b
Gain Loss On Investment Securities ($14.0m) ($40.0m) ($95.0m) $49.0m
Gain Loss On Sale Of Business ($776.0m) $0 $0
Gain Loss On Sale Of PPE ($104.0m) ($251.0m) ($64.0m) ($168.0m)
Gains on disposal of intangible assets ($1.3b) ($1.5b) ($1.9b) ($1.2b) ($1.0b) ($513.0m) ($104.0m) ($251.0m) ($64.0m) ($168.0m)
Goodwill $11.7b $11.8b $11.7b $11.7b $11.8b $20.0b $19.8b $20.0b $21.0b $21.2b
Increase in inventories ($343.0m) ($548.0m) ($13.0m) ($316.0m) ($621.0m) $1.6b $3.9b ($669.0m) ($131.0m) ($755.0m)
Increase in trade and other payables and provisions ($341.0m) $415.0m ($103.0m) $868.0m $1.7b $1.4b $1.2b $2.4b $862.0m $1.3b
Increase in trade and other receivables $1.6b $83.0m ($523.0m) ($898.0m) ($739.0m) ($961.0m) ($1.3b) ($1.4b) ($1.6b) ($1.7b)
Interest Received CFI $60.0m $287.0m $343.0m $286.0m
Interest received $140.0m $164.0m $193.0m $124.0m $47.0m $34.0m $60.0m $287.0m $343.0m $286.0m
Investing Cash Flow ($3.0b) ($4.1b) ($8.0b) ($6.8b)
Issuance Of Capital Stock $29.0m $33.0m ($43.0m) ($481.0m)
Issue of loans and borrowings $2.5b $2.0b $3.0b $500.0m $3.0b $12.9b $3.8b $6.5b $15.0m
Movement in profit-participation liability $150.0m $40.0m $20.0m $190.0m
Movement in short-term borrowings ($303.0m) $336.0m ($98.0m) ($516.0m) $288.0m ($276.0m) $74.0m $161.0m ($31.0m) $364.0m
Net Business Purchase And Sale ($1.1b) ($1.2b) ($3.9b) ($1.2b)
Net Foreign Currency Exchange Gain Loss $16.0m $34.0m $42.0m $31.0m
Net Intangibles Purchase And Sale ($1.0b) ($2.1b) ($2.5b) ($3.0b)
Net PPE Purchase And Sale ($809.0m) ($1.2b) ($1.9b) ($2.8b)
Non-cash and other movements ($492.0m) ($524.0m) ($290.0m) $378.0m ($276.0m) $95.0m ($692.0m) ($386.0m) ($121.0m) $662.0m
Other Non Cash Items $639.0m $1.5b $1.5b $1.8b
Own shares purchased by Employee Benefit Trusts ($149.0m) ($81.0m) ($521.0m)
Payment of Acerta Pharma share purchase liability $0 $0 ($920.0m) ($867.0m) ($833.0m)
Payment of contingent consideration from business combinations ($293.0m) ($434.0m) ($349.0m) ($709.0m) ($822.0m) ($643.0m) ($772.0m) ($826.0m) ($1.0b) ($1.2b)
Payments Of Lease Liabilities Classified As Financing Activities $186.0m $207.0m $240.0m $244.0m $268.0m $316.0m $372.0m
Payments To Acquire Or Redeem Entitys Shares $149.0m $81.0m $521.0m
Payments to acquire non-controlling interests ($149.0m) ($183.0m)
Payments to associates and joint ventures ($41.0m) ($76.0m) ($187.0m) ($74.0m) ($8.0m) ($92.0m) ($26.0m) ($80.0m) ($158.0m) ($10.0m)
Payments upon vesting of employee share awards attributable to business combinations ($211.0m) ($215.0m) ($84.0m) ($3.0m)
Proceeds From Borrowings Classified As Financing Activities $2.5b $2.0b $3.0b $500.0m $3.0b $12.9b $3.8b $6.5b $15.0m
Proceeds From Issuing Shares $47.0m $43.0m $34.0m $3.5b $30.0m $29.0m $29.0m $33.0m $38.0m $40.0m
Proceeds from issue of share capital $47.0m $43.0m $34.0m $3.5b $30.0m $29.0m $29.0m $33.0m $38.0m $40.0m
Profit before tax $3.6b $2.2b $2.0b $1.5b $3.9b ($265.0m) $2.5b $6.9b $8.7b $12.4b
Purchase Of Business ($1.1b) ($1.2b) ($3.9b) ($1.2b)
Purchase Of Intangible Assets Classified As Investing Activities $868.0m $294.0m $328.0m $1.5b $1.6b $1.1b $1.5b $2.4b $2.7b $3.1b
Purchase Of Intangibles ($1.5b) ($2.4b) ($2.7b) ($3.1b)
Purchase Of PPE $1.3b $1.0b $979.0m $961.0m $1.1b ($1.1b) ($1.4b) ($1.9b) ($2.8b)
Purchase of intangible assets ($868.0m) ($294.0m) ($328.0m) ($1.5b) ($1.6b) ($1.1b) ($1.5b) ($2.4b) ($2.7b) ($3.1b)
Repayment of loans and borrowings ($1.8b) ($1.4b) ($1.5b) ($1.6b) ($4.8b) ($1.3b) ($4.9b) ($4.7b) ($2.0b)
Repayment of obligations under leases ($14.0m) ($186.0m) ($207.0m) ($240.0m) ($244.0m) ($268.0m) ($316.0m) ($372.0m)
Repayments Of Borrowings Classified As Financing Activities $1.8b $1.4b $1.5b $1.6b $4.8b $1.3b $4.9b $4.7b $2.0b
Sale Of Business $0 $0 $13.0m $0
Sale Of Intangibles $447.0m $291.0m $123.0m $136.0m
Sale Of PPE $282.0m $132.0m $55.0m $13.0m
Share of after tax losses in associates and joint ventures $33.0m $55.0m $113.0m $64.0m $5.0m $12.0m $28.0m $7.0m
Profit or Loss $3.4b $2.9b $2.0b $1.2b $3.1b $115.0m $3.3b $6.0b $7.0b $10.2b
Capital Expenditure ($2.6b) ($3.8b) ($4.6b) ($5.9b)
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $82.0m $83.0m $12.0m $37.0m $106.0m $13.0m $282.0m $132.0m $55.0m $13.0m
Purchase of property, plant and equipment ($1.4b) ($1.3b) ($1.0b) ($979.0m) ($961.0m) ($1.1b) ($1.1b) ($1.4b) ($1.9b) ($2.8b)
Net Investment Purchase And Sale ($117.0m) ($7.0m) $12.0m ($98.0m)
Purchase Of Investment ($159.0m) ($136.0m) ($96.0m) ($229.0m)
Purchase of non-current asset investments ($230.0m) ($96.0m) ($102.0m) ($13.0m) ($119.0m) ($184.0m) ($45.0m) ($136.0m) ($96.0m) ($229.0m)
Sale Of Investment $42.0m $129.0m $108.0m $131.0m
Movement in short-term investments, fixed deposits and other investing instruments ($166.0m) ($345.0m) $405.0m $194.0m $745.0m $96.0m ($114.0m) $97.0m $30.0m $131.0m
Net Other Investing Changes $20.0m $190.0m
Net cash outflow from investing activities ($4.0b) ($2.3b) $963.0m ($657.0m) ($285.0m) ($11.1b) ($3.0b) ($4.1b) ($8.0b) ($6.8b)
Issuance Of Debt $0 $3.8b $6.5b $15.0m
Long Term Debt Issuance $0 $3.8b $6.5b $15.0m
Net Issuance Payments Of Debt ($1.2b) ($965.0m) $1.8b ($1.6b)
Net Long Term Debt Issuance ($1.3b) ($1.1b) $1.8b ($2.0b)
Net Short Term Debt Issuance $74.0m $161.0m ($31.0m) $364.0m
Long Term Debt Payments ($1.3b) ($4.9b) ($4.7b) ($2.0b)
Repayment Of Debt ($1.3b) ($4.9b) ($4.7b) ($2.0b)
Common Stock Issuance $29.0m $33.0m ($43.0m) ($481.0m)
Net Common Stock Issuance $29.0m $33.0m ($43.0m) ($481.0m)
Cash Dividends Paid ($4.4b) ($4.5b) ($4.6b) ($5.0b)
Common Stock Dividend Paid ($4.4b) ($4.5b) ($4.6b) ($5.0b)
Dividends Paid Classified As Financing Activities $3.6b $3.5b $3.5b $3.6b $3.6b $3.9b $4.4b $4.5b $4.6b $5.0b
Dividends Recognised As Distributions To Owners Of Parent Relating To Current Year $1.1b $1.1b $1.1b $1.2b $1.2b $1.4b $1.4b $1.4b $1.6b $1.6b
Dividends Recognised As Distributions To Owners Of Parent Relating To Prior Years $2.4b $2.4b $2.4b $2.4b $2.5b $2.5b $3.0b $3.0b $3.1b $3.2b
Dividends paid ($4k) ($4k) ($3k) ($4k) ($4k) ($4k) ($4k) ($4k) ($5k) ($5k)
Hedge contracts relating to dividend payments $18.0m ($20.0m) ($67.0m) $4.0m ($101.0m) ($29.0m) ($127.0m) ($19.0m) $16.0m $113.0m
Net Other Financing Charges ($1.0b) ($886.0m) ($817.0m) ($70.0m)
Net cash inflow before financing activities $176.0m $1.2b $3.6b $2.3b $4.5b ($5.1b) $6.8b $6.3b $3.9b $7.8b
Net cash outflow from financing activities ($1.3b) ($2.9b) ($2.0b) ($1.8b) ($2.2b) $3.6b ($6.8b) ($6.6b) ($4.0b) ($7.5b)
Effect Of Exchange Rate Changes ($80.0m) ($60.0m) ($93.0m) $46.0m
Exchange rate effects $21.0m ($66.0m) ($38.0m) $5.0m $12.0m ($62.0m) ($80.0m) ($60.0m) ($93.0m) $46.0m
Net increase/(decrease) in Cash and cash equivalents in the period ($1.1b) ($1.7b) $1.5b $547.0m $2.3b ($1.4b) $25.0m ($286.0m) ($115.0m) $223.0m
Cash and cash equivalents at the beginning of the period $4.9b $3.2b $4.7b $5.2b $7.5b $6.0b $6.0b $5.6b $5.4b $5.7b
Change In Cash Supplemental As Reported $25.0m ($286.0m) ($115.0m) $223.0m
Interest Paid Classified As Operating Activities $677.0m $698.0m $676.0m $774.0m $733.0m $721.0m $849.0m $1.1b $1.3b $1.3b
Income Taxes Paid Refund Classified As Operating Activities $412.0m $454.0m $537.0m $1.1b $1.6b $1.7b $1.6b $2.4b $2.8b $2.8b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.